No results, please enter a search term above
|Date of Alert|
|No Health Alerts Found|
|Monkeypox Vaccination Strategy and Prioritization of First Doses||Advisory||Aug 4, 2022|
|Pain Management Recommendations for Monkeypox||Update||Aug 2, 2022|
|Tecovirimat Treatment for Monkeypox||Update||Jul 27, 2022|
|Update on Clinical Presentation and Epidemiology on Monkeypox in Philadelphia||Update||Jul 8, 2022|
|Exposure Risk Assessment and Clinical Manifestation of Monkeypox||Advisory||Jun 8, 2022|
Clinical presentation in the current outbreak has been atypical and often there is no prodrome. All patients have been found to have a skin rash upon physical examination, however the rash is often not scattered and is instead limited to one body site. Lymphadenopathy has not been universal during the current outbreak.
Key epidemiologic risk factors have included (1) contact with a person or people with a similar appearing rash or a diagnosis of monkeypox and (2) close or intimate contact with people in a social network experiencing monkeypox activity (e.g., men who have sex with men and transgender persons who have sex with men who meet partners through an online website, digital app, or social event).
The Health Department has begun vaccinating Philadelphians who are at high-risk. Currently, clinics are being offered on a rolling, invitation-only basis. Individuals who believe that they are at a high risk of being exposed to monkeypox can call the Call Center at 215-685-5488 to see if they are eligible to be vaccinated.
To be eligible, people must meet all of the following conditions:
The eligibility criteria has been established based on who may be at the highest-risk of exposure to monkeypox. As more vaccine is delivered, more people will be invited to these vaccine clinics.
While the vaccine is normally a 2-dose series, the Department of Public Health is currently only administering one dose to patients due to the limited supply of the vaccine. One dose still provides some protection against monkeypox and provides the opportunity to provide vaccine to more individuals who may be at high-risk of contracting monkeypox.
The following should be considered for management of suspected cases:
The Centers for Disease Control and Prevention (CDC) recently conducted a Clinical Outreach and Communication Activity (COCA) call that provided updated information on the clinical diagnosis and treatment of monkeypox. Clinicians are highly encouraged to watch the recording for further information regarding recognition and testing of monkeypox including clinical case studies and photos from the current outbreak.
The CDC will be hosting another COCA call on Tuesday, July 26 to provide additional updates on the epidemiology of the monkeypox outbreak, commercial testing capacity, how to obtain and use TPOXX (tecovirimat) to treat monkeypox, and vaccine strategy,
There are no patient or community resources for Monkeypox.
There are no posters for Monkeypox.